Zimmer Biomet Holdings, Inc. (ZBH) Stake Cut by Delphi Management Inc. MA

Delphi Management Inc. MA reduced its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 13.1% during the third quarter, Holdings Channel reports. The fund owned 18,683 shares of the company’s stock after selling 2,812 shares during the period. Zimmer Biomet Holdings comprises approximately 1.5% of Delphi Management Inc. MA’s portfolio, making the stock its 8th largest position. Delphi Management Inc. MA’s holdings in Zimmer Biomet Holdings were worth $2,429,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Public Employees Retirement Association of Colorado boosted its position in Zimmer Biomet Holdings by 1.2% in the second quarter. Public Employees Retirement Association of Colorado now owns 37,826 shares of the company’s stock valued at $4,553,000 after buying an additional 463 shares during the period. Sumitomo Mitsui Asset Management Company LTD boosted its position in Zimmer Biomet Holdings by 7.2% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 14,924 shares of the company’s stock valued at $1,796,000 after buying an additional 1,007 shares during the period. BP PLC boosted its position in Zimmer Biomet Holdings by 84.2% in the second quarter. BP PLC now owns 35,000 shares of the company’s stock valued at $4,212,000 after buying an additional 16,000 shares during the period. Enterprise Financial Services Corp boosted its position in Zimmer Biomet Holdings by 173.9% in the second quarter. Enterprise Financial Services Corp now owns 1,260 shares of the company’s stock valued at $151,000 after buying an additional 800 shares during the period. Finally, Wedge Capital Management L L P NC boosted its position in Zimmer Biomet Holdings by 20.0% in the second quarter. Wedge Capital Management L L P NC now owns 1,501,841 shares of the company’s stock valued at $161,215,000 after buying an additional 250,048 shares during the period. Hedge funds and other institutional investors own 86.62% of the company’s stock.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) opened at 117.33 on Monday. The company has a market capitalization of $23.51 billion, a P/E ratio of 78.22 and a beta of 1.20. The stock’s 50 day moving average price is $112.40 and its 200 day moving average price is $117.32. Zimmer Biomet Holdings, Inc. has a 52-week low of $88.27 and a 52-week high of $133.21.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings results on Tuesday, January 31st. The company reported $2.14 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.11 by $0.03. Zimmer Biomet Holdings had a return on equity of 16.66% and a net margin of 3.90%. The firm earned $2.01 billion during the quarter, compared to the consensus estimate of $1.98 billion. During the same quarter in the previous year, the business earned $2.09 earnings per share. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. On average, equities research analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.56 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, January 27th. Shareholders of record on Friday, December 30th were given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date was Wednesday, December 28th. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 65.31%.

COPYRIGHT VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Stake Cut by Delphi Management Inc. MA” was originally reported by sleekmoney and is the property of of sleekmoney. If you are viewing this news story on another site, it was stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this news story can be viewed at http://sleekmoney.com/zimmer-biomet-holdings-inc-zbh-stake-cut-by-delphi-management-inc-ma/1658022.html.

ZBH has been the topic of several research reports. Northcoast Research cut Zimmer Biomet Holdings from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 8th. Needham & Company LLC upgraded Zimmer Biomet Holdings from a “buy” rating to a “strong-buy” rating and cut their price objective for the company from $150.00 to $148.00 in a research note on Tuesday, November 1st. RBC Capital Markets upped their price objective on Zimmer Biomet Holdings from $130.00 to $133.00 and gave the company an “outperform” rating in a research note on Wednesday, February 1st. Robert W. Baird restated an “outperform” rating and set a $136.00 price objective (up previously from $130.00) on shares of Zimmer Biomet Holdings in a research note on Wednesday, February 1st. Finally, J P Morgan Chase & Co set a $134.00 price objective on Zimmer Biomet Holdings and gave the company a “buy” rating in a research note on Thursday, January 5th. Four analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $133.75.

In other Zimmer Biomet Holdings news, insider David A. Jr. Nolan sold 5,050 shares of the business’s stock in a transaction dated Friday, December 2nd. The stock was sold at an average price of $101.11, for a total transaction of $510,605.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.22% of the stock is currently owned by insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc, formerly Zimmer Holdings, Inc, is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

5 Day Chart for NYSE:ZBH

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/zimmer-biomet-holdings-inc-zbh-stake-cut-by-delphi-management-inc-ma/1658022.html

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *